Ambit Biosciences Corp (AMBI) - NASDAQ
AMBI is defunct.
  • Aug. 13, 2014, 12:56 PM
    • Ambit Biosciences (AMBI -2%) Q2 results: Revenues: $26K (-99.8%); Net Loss: ($10.6M) (-493.0%); Quick Assets: $52.8M (-25.8%).
    • No financial guidance given.
    | Aug. 13, 2014, 12:56 PM
  • Aug. 12, 2014, 4:23 PM
    • Ambit Biosciences (NASDAQ:AMBI): Q2 Net loss of -$8.28M
    • Revenue of $0.03M (-99.7% Y/Y) beats by $0.02M.
    | Aug. 12, 2014, 4:23 PM
Company Description
Ambit Biosciences Corp is a biotechnology company. It is engaged in discovering, developing & commercializing small molecule therapeutics for the treatment of cancer.
Sector: Healthcare
Industry: Biotechnology
Country: United States